CELG-RI

Bristol-Myers Squibb Company (NYSE:BMY) is a major American pharmaceutical corporation founded in 1933 through the merger of Bristol-Myers Company and E.R. Squibb & Sons. Headquartered in Princeton, New Jersey, the company has evolved into one of the world's leading biopharmaceutical companies, focusing on the discovery, development, and commercialization of innovative medicines for serious diseases. Over its nine-decade history, Bristol-Myers Squibb has built a reputation as a pioneer in oncology, immunology, cardiovascular disease, and fibrosis treatments, with a particular emphasis on transforming patient outcomes through cutting-edge therapeutic approaches.